The non-surgical treatment with Dr Allen’s Device reduces the size of enlarged prostate and helps its users to avoid contracting a coronavirus, a new scientific article reveals. Titled “Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively” and published in the International Journal of Quality Innovation, https://link.springer.com/article/10.1186/s40887-020-00035-0 the article shows that the treatment with a wearable Dr Allen’s Device reduces the size of enlarged prostate and, consequently, relieves lower urinary tract symptoms (LUTS).

Moreover, the at-home treatment with Dr Allen’s Device minimizes the risk of contracting coronavirus by reducing the number of hospital visits by older men.

This is especially important as the number of coronavirus cases is alarmingly on the rise. At present, India has the second highest number of Covid-19 cases after the United States.

Thermobalancing therapy with Dr Allen’s Device is a side-effects-free and easy-to-use treatment. Dr Allen’s Device is USPTO-patented and has been registered with the British Medical Healthcare Agency (MHRA) since 2010, so its safety is confirmed, regulated, and has been well tested over the decade.

BPH and chronic prostatitis treatments offered by urologists are risky

Treatments offered by urologists to patients with benign prostatic hyperplasia (BPH) and chronic prostatitis do not treat the affected prostate gland. They typically prescribe medications to ease pain and urinary symptoms or offer surgical procedures to remove a part or the whole prostate. Dr Allen’s Device is the only treatment option, which improves blood circulation in the prostate gland and so targets these prostate conditions at their root, without any damage to its users.

The risks and flaws of BPH drugs have been highlighted in a recent scientific study. In May 2020, the Frontiers in Pharmacology Journal published a review, titled ‘Efficacy and side effects of drugs commonly used for the treatment of lower urinary tract symptoms associated with BPH’. It provides current comprehensive perspectives on the mechanisms of action, efficacy, and adverse reactions associated with the drugs most commonly used for the treatment of BPH.

All drugs for men with BPH and chronic prostatitis are found to be causing more nasty health problems. Thus, the α1-blockers group is associated with many adverse reactions, such as postural hypotension, dizziness, asthenia, abnormal ejaculation, and intraoperative floppy iris syndrome. The other group of BPH drugs is not any better: 5α-reductase inhibitors (5-ARIs) decrease libido and cause gynecomastia, erectile dysfunction and sexual side effects.

Urologists can offer different surgical procedures, such as transurethral resection of the prostate (TURP), transurethral microwave thermotherapy (TUMT), transurethral laser ablation and many others. All these procedures have a negative impact on men’s health, which makes it difficult to choose the best option among them. Most side effects after a prostate surgery are associated with sexual dysfunction, which in turn, causes mental health issues and depression in almost 25% of patients.

Dangers of hospital visits during the Covid-19 pandemic

A new medical article confirms that the wider use of Dr Allen’s Device in healthcare systems will decrease male visits to hospitals, diminishing the risks of contracting a viral infection and transmitting it to others during a coronavirus outbreak or another pandemic.

This article on “BPH and chronic prostatitis Thermobalancing Therapy can prevent sexual dysfunction and depression linked to medications: importance during a pandemic” reveals that the at-home treatment with Dr Allen’s Device reduces the need for long-term courses of BPH and chronic prostatitis medications preventing retrograde ejaculation, sexual dysfunction, depression, and other health disorders.

Opting for Dr Allen’s Device is important as men undergoing prostate surgeries during a pandemic are at a greater risk of contracting coronavirus. The International Journal of Clinical Practice has published an article on ‘Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in ageing male’ showing that in March – April 2020, out of 18 BPH patients who were admitted and treated in a hospital, 10 men (i.e. 55.5%) got infected with the coronavirus, 2 of them were transferred to the intensive care unit and 1 man even died.

Dr Allen’s response to Coronavirus

The fact that Dr Allen’s Device helps men with enlarged prostate to effortlessly reduce prostate volume and ease urination problems has been confirmed by its successful 10-year presence on the market and solid medical data. Clinical studies on Thermobalancing therapy and Dr Allen’s Device, registered with the World Health Organisation, confirm its effectiveness for men with BPH and chronic prostatitis.

Many scientific articles published in leading medical journals are available on the dedicated Fine Treatment webpage: https://finetreatment.com/thermobalancing-therapy-medical-scientific-data/. Founded by Dr Simon Allen and Ariana Adjani, Fine Treatment is an innovative healthcare company that conducts pioneering medical research and provides Dr Allen’s Devices for effective at-home treatment. Fine Treatment is a UK Department for International Trade (DIT) registered supplier to international buyers.

Throughout the Covid-19 pandemic and the global lockdown, Fine Treatment has remained focused on helping people with chronic pain and different health conditions. Fine Treatment https://finetreatment.com/ is committed to improving health and wellbeing of people worldwide. Dr Allen’s Devices available around the world, with free international delivery on offer.